Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a history: a randomized trial

The use of enoxaparin in addition to standard high-risk care does not reduce the risk of recurrence of preeclampsia and small-for-gestational-age infants in a subsequent pregnancy.